Stayer Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 39.22%
- Profit Growth -62.81%
- Ebitda 111.36%
- Net Worth 2.85%
- Total Assets 30.60%
About Stayer Pharma
Stayer Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2016 (Eight years and nine months 5 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tejas Bachute, Vishnu Birajdar, and Gaytri Patil serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900MH2016PTC280641
-
Company No.
280641
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 May 2016
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Stayer Pharma Private Limited offer?
Stayer Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs, Antipyretic Medication, Paracetamol Suspension, Antacid Drugs, Rabeprazole Tablets, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Common Disease Medicines, Pharmaceutical Syrup.
Who are the key members and board of directors at Stayer Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejas Bachute
|
Director | 28-Mar-2018 | Current |
|
Vishnu Birajdar
|
Director | 16-Aug-2016 | Current |
|
Gaytri Patil
|
Director | 03-May-2017 | Current |
Financial Performance of Stayer Pharma.
Stayer Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 39.22% increase. The company also saw a substantial fall in profitability, with a 62.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stayer Pharma?
In 2019, Stayer Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stayer Pharma?
Unlock and access historical data on people associated with Stayer Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stayer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stayer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
